{"id":3366,"date":"2022-04-14T17:49:00","date_gmt":"2022-04-14T15:49:00","guid":{"rendered":"https:\/\/hemerion.com\/hemerion-leve-35-millions-e-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/"},"modified":"2022-06-03T17:19:34","modified_gmt":"2022-06-03T15:19:34","slug":"hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome","status":"publish","type":"post","link":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/","title":{"rendered":"Hemerion l\u00e8ve 3,5 millions \u20ac pour financer le d\u00e9veloppement de nouvelles solutions pour le traitement du glioblastome"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Un an apr\u00e8s la premi\u00e8re lev\u00e9e de fonds, le nouveau financement de 3,55 M d\u2019euros obtenu par Hemerion permet d&rsquo;acc\u00e9l\u00e9rer la mise en place d\u2019essais cliniques internationaux dans le traitement du glioblastome, le cancer du cerveau le plus agressif.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hemerion Therapeutics a d\u00e9j\u00e0 initi\u00e9 <a href=\"https:\/\/hemerion.com\/fr\/resultats-cliniques-preliminaires-positifs-pour-le-traitement-du-glioblastome-developpe-par-hemerion-therapeutics\/\">son programme clinique avec une <strong>premi\u00e8re \u00e9tude concluante chez les patients atteints d\u2019un glioblastome<\/strong><\/a>. \u00c0 terme, <a href=\"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/\">les solutions th\u00e9rapeutiques d\u00e9velopp\u00e9es par Hemerion<\/a> pourraient \u00eatre int\u00e9gr\u00e9es dans le standard de soin et am\u00e9liorer significativement <strong>la survie et la qualit\u00e9 de vie<\/strong> des patients sans impacter les m\u00e9thodes de travail des neurochirurgiens.<\/p>\n\n\n\n<h2 class=\"h3 wp-block-heading\">Un financement d\u2019amor\u00e7age \u00e9lev\u00e9 qui contribue directement au d\u00e9veloppement clinique international<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Les fonds FIRA NORD EST 2 (Finovam gestion), CapTech Sant\u00e9 Nutrition, Nord France Amor\u00e7age et plusieurs business angels concourent \u00e0 cet investissement cumul\u00e9 de <strong>2,55 millions \u20ac<\/strong>. Ces op\u00e9rations en fonds propres, ou quasi-fonds propres sont compl\u00e9t\u00e9es par un pr\u00eat d\u2019amor\u00e7age de <a href=\"https:\/\/www.bpifrance.com\/\">Bpifrance<\/a> pour un montant de 1 million \u20ac.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ce nouveau financement fait suite au premier tour assur\u00e9 par les fondateurs d\u2019Hemerion, la Fondation de l\u2019Universit\u00e9 de Lille, Bpifrance et un entrepreneur business angel.<\/p>\n\n\n\n<h2 class=\"h3 wp-block-heading\">Une acc\u00e9l\u00e9ration des d\u00e9veloppements cliniques, notamment aux \u00c9tats-Unis<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ce tour de table vise notamment \u00e0 financer d\u00e8s 2023 un essai clinique international de phase II aux USA et en Europe.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hemerion travaille aujourd\u2019hui avec la Food and Drugs Administration (FDA) pour obtenir le label Investigational New Drug (IND). Ce label permettra la mise en place d\u2019un essai clinique de phase II au premier semestre 2023, en collaboration avec <a href=\"https:\/\/www.mountsinai.org\/\">l\u2019H\u00f4pital Mount Sinai<\/a> de New York. Portant sur 10 \u00e0 15 patients, l\u2019essai vise \u00e0 confirmer la s\u00e9curit\u00e9 de la nouvelle plateforme technologique Heliance et pr\u00e9figure une nouvelle phase d\u2019essais cliniques, \u00e9tape indispensable \u00e0 la mise sur le march\u00e9 de la solution Hemerion dans le <strong>traitement du glioblastome<\/strong>.<\/p>\n\n\n\n<h2 class=\"h3 wp-block-heading\">Des ressources pour de nouvelles applications th\u00e9rapeutiques<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ce nouveau financement permet \u00e9galement \u00e0 Hemerion de d\u00e9velopper le portfolio d\u2019applications th\u00e9rapeutiques de sa technologie. Plusieurs \u00e9valuations pr\u00e9cliniques sont d\u00e9j\u00e0 en cours pour valider l\u2019efficacit\u00e9 de la solution th\u00e9rapeutique dans le <strong>traitement d\u2019autres types de cancers<\/strong>. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un an apr\u00e8s la premi\u00e8re lev\u00e9e de fonds, le nouveau financement de 3,55 M d\u2019euros obtenu par Hemerion permet d&rsquo;acc\u00e9l\u00e9rer la mise en place d\u2019essais cliniques internationaux dans le traitement du glioblastome, le cancer du cerveau le plus agressif. Hemerion Therapeutics a d\u00e9j\u00e0 initi\u00e9 son programme clinique avec une premi\u00e8re \u00e9tude concluante chez les patients &#8230; <\/p>\n<p class=\"read-more-container\"><a title=\"Hemerion l\u00e8ve 3,5 millions \u20ac pour financer le d\u00e9veloppement de nouvelles solutions pour le traitement du glioblastome\" class=\"read-more button\" href=\"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/#more-3366\" aria-label=\"En savoir plus sur Hemerion l\u00e8ve 3,5 millions \u20ac pour financer le d\u00e9veloppement de nouvelles solutions pour le traitement du glioblastome\">Lire plus<\/a><\/p>\n","protected":false},"author":207845438,"featured_media":3357,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_jet_sm_ready_style":"","_jet_sm_style":"","_jet_sm_controls_values":"","_jet_sm_fonts_collection":"","_jet_sm_fonts_links":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_wpcom_ai_launchpad_first_post":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[6342],"tags":[],"class_list":["post-3366","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>3,5 millions \u20ac pour traiter le glioblastome<\/title>\n<meta name=\"description\" content=\"La lev\u00e9e de fonds de 3,55 M d\u2019euros permet d&#039;acc\u00e9l\u00e9rer les essais cliniques internationaux dans le traitement du glioblastome.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"3,5 millions \u20ac pour traiter le glioblastome\" \/>\n<meta property=\"og:description\" content=\"La lev\u00e9e de fonds de 3,55 M d\u2019euros permet d&#039;acc\u00e9l\u00e9rer les essais cliniques internationaux dans le traitement du glioblastome.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/\" \/>\n<meta property=\"og:site_name\" content=\"Hemerion\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-14T15:49:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-03T15:19:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hemerion.com\/wp-content\/uploads\/hemerion-fund-raising.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Simon Delmotte\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HemerionTx\" \/>\n<meta name=\"twitter:site\" content=\"@HemerionTx\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simon Delmotte\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/\"},\"author\":{\"name\":\"Simon Delmotte\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/person\\\/ec5b45c7f7f52200ee5073ce247a86c7\"},\"headline\":\"Hemerion l\u00e8ve 3,5 millions \u20ac pour financer le d\u00e9veloppement de nouvelles solutions pour le traitement du glioblastome\",\"datePublished\":\"2022-04-14T15:49:00+00:00\",\"dateModified\":\"2022-06-03T15:19:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/\"},\"wordCount\":391,\"publisher\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-fund-raising.jpg?fit=2000%2C1333&ssl=1\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/\",\"name\":\"3,5 millions \u20ac pour traiter le glioblastome\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-fund-raising.jpg?fit=2000%2C1333&ssl=1\",\"datePublished\":\"2022-04-14T15:49:00+00:00\",\"dateModified\":\"2022-06-03T15:19:34+00:00\",\"description\":\"La lev\u00e9e de fonds de 3,55 M d\u2019euros permet d'acc\u00e9l\u00e9rer les essais cliniques internationaux dans le traitement du glioblastome.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-fund-raising.jpg?fit=2000%2C1333&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-fund-raising.jpg?fit=2000%2C1333&ssl=1\",\"width\":2000,\"height\":1333,\"caption\":\"Lev\u00e9e de fonds\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hemerion l\u00e8ve 3,5 millions \u20ac pour financer le d\u00e9veloppement de nouvelles solutions pour le traitement du glioblastome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\",\"name\":\"Hemerion\",\"description\":\"Advancing cancer therapies at the speed of light\",\"publisher\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\",\"name\":\"Hemerion\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-logo.png?fit=1581%2C460&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-logo.png?fit=1581%2C460&ssl=1\",\"width\":1581,\"height\":460,\"caption\":\"Hemerion\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/HemerionTx\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hemerion-therapeutics\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCWwcUj-aSdo32OYwN5vjf8Q\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/person\\\/ec5b45c7f7f52200ee5073ce247a86c7\",\"name\":\"Simon Delmotte\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g\",\"caption\":\"Simon Delmotte\"},\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/author\\\/simondelmotte\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"3,5 millions \u20ac pour traiter le glioblastome","description":"La lev\u00e9e de fonds de 3,55 M d\u2019euros permet d'acc\u00e9l\u00e9rer les essais cliniques internationaux dans le traitement du glioblastome.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/","og_locale":"fr_FR","og_type":"article","og_title":"3,5 millions \u20ac pour traiter le glioblastome","og_description":"La lev\u00e9e de fonds de 3,55 M d\u2019euros permet d'acc\u00e9l\u00e9rer les essais cliniques internationaux dans le traitement du glioblastome.","og_url":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/","og_site_name":"Hemerion","article_published_time":"2022-04-14T15:49:00+00:00","article_modified_time":"2022-06-03T15:19:34+00:00","og_image":[{"width":2000,"height":1333,"url":"https:\/\/hemerion.com\/wp-content\/uploads\/hemerion-fund-raising.jpg","type":"image\/jpeg"}],"author":"Simon Delmotte","twitter_card":"summary_large_image","twitter_creator":"@HemerionTx","twitter_site":"@HemerionTx","twitter_misc":{"\u00c9crit par":"Simon Delmotte","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/#article","isPartOf":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/"},"author":{"name":"Simon Delmotte","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/person\/ec5b45c7f7f52200ee5073ce247a86c7"},"headline":"Hemerion l\u00e8ve 3,5 millions \u20ac pour financer le d\u00e9veloppement de nouvelles solutions pour le traitement du glioblastome","datePublished":"2022-04-14T15:49:00+00:00","dateModified":"2022-06-03T15:19:34+00:00","mainEntityOfPage":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/"},"wordCount":391,"publisher":{"@id":"https:\/\/hemerion.com\/fr\/#organization"},"image":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-fund-raising.jpg?fit=2000%2C1333&ssl=1","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/","url":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/","name":"3,5 millions \u20ac pour traiter le glioblastome","isPartOf":{"@id":"https:\/\/hemerion.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/#primaryimage"},"image":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-fund-raising.jpg?fit=2000%2C1333&ssl=1","datePublished":"2022-04-14T15:49:00+00:00","dateModified":"2022-06-03T15:19:34+00:00","description":"La lev\u00e9e de fonds de 3,55 M d\u2019euros permet d'acc\u00e9l\u00e9rer les essais cliniques internationaux dans le traitement du glioblastome.","breadcrumb":{"@id":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/#primaryimage","url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-fund-raising.jpg?fit=2000%2C1333&ssl=1","contentUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-fund-raising.jpg?fit=2000%2C1333&ssl=1","width":2000,"height":1333,"caption":"Lev\u00e9e de fonds"},{"@type":"BreadcrumbList","@id":"https:\/\/hemerion.com\/fr\/hemerion-leve-35-millions-euros-pour-financer-le-developpement-de-nouvelles-solutions-pour-le-traitement-du-glioblastome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hemerion.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Hemerion l\u00e8ve 3,5 millions \u20ac pour financer le d\u00e9veloppement de nouvelles solutions pour le traitement du glioblastome"}]},{"@type":"WebSite","@id":"https:\/\/hemerion.com\/fr\/#website","url":"https:\/\/hemerion.com\/fr\/","name":"Hemerion","description":"Advancing cancer therapies at the speed of light","publisher":{"@id":"https:\/\/hemerion.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hemerion.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/hemerion.com\/fr\/#organization","name":"Hemerion","url":"https:\/\/hemerion.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-logo.png?fit=1581%2C460&ssl=1","contentUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-logo.png?fit=1581%2C460&ssl=1","width":1581,"height":460,"caption":"Hemerion"},"image":{"@id":"https:\/\/hemerion.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/HemerionTx","https:\/\/www.linkedin.com\/company\/hemerion-therapeutics\/","https:\/\/www.youtube.com\/channel\/UCWwcUj-aSdo32OYwN5vjf8Q"]},{"@type":"Person","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/person\/ec5b45c7f7f52200ee5073ce247a86c7","name":"Simon Delmotte","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g","caption":"Simon Delmotte"},"url":"https:\/\/hemerion.com\/fr\/author\/simondelmotte\/"}]}},"jetpack_shortlink":"https:\/\/wp.me\/pd9WhZ-Si","jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-fund-raising.jpg?fit=2000%2C1333&ssl=1","_links":{"self":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/3366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/users\/207845438"}],"replies":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/comments?post=3366"}],"version-history":[{"count":6,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/3366\/revisions"}],"predecessor-version":[{"id":3474,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/3366\/revisions\/3474"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/media\/3357"}],"wp:attachment":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/media?parent=3366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/categories?post=3366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/tags?post=3366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}